| Short Descr | Arteriovenous fistula, acquired |
| CMS-HCC v22 | 108 - Vascular Disease |
| CMS-HCC v24 | 108 - Vascular Disease |
| ESRD-HCC v21 | 108 - Vascular Disease |
| ESRD-HCC v24 | 108 - Vascular Disease |
| Home Health Clinical Group | MMTA_CARDIAC |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2015-10-01 | Added | Code established |
|
Code
|
Description
|
|---|---|
| A9574 | Air polymer-type a intrauterine foam, 0.1 ml |
| G0010 | Administration of hepatitis b vaccine |
| G0027 | Semen analysis; presence and/or motility of sperm excluding huhner |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician |
| G0141 | Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician |
| G0143 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision |
| G0144 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
| G0147 | Screening cytopathology smears, cervical or vaginal, performed by automated system under physician supervision |
| G0148 | Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
| J0725 | Injection, chorionic gonadotropin, per 1,000 usp units |
| J0900 | Injection, testosterone enanthate and estradiol valerate, up to 1 cc [deleted] |
| J1000 | Injection, depo-estradiol cypionate, up to 5 mg |
| J1060 | Injection, testosterone cypionate and estradiol cypionate, up to 1 ml [deleted] |
| J1071 | Injection, testosterone cypionate, 1 mg |
| J1094 | Injection, dexamethasone acetate, 1 mg |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg |
| J1380 | Injection, estradiol valerate, up to 10 mg |
| J1410 | Injection, estrogen conjugated, per 25 mg |
| J1620 | Injection, gonadorelin hydrochloride, per 100 mcg |
| J2370 | Injection, phenylephrine hcl, up to 1 ml [deleted] |
| J2675 | Injection, progesterone, per 50 mg |
| J3120 | Injection, testosterone enanthate, up to 100 mg [deleted] |
| J3121 | Injection, testosterone enanthate, 1 mg |
| J3130 | Injection, testosterone enanthate, up to 200 mg [deleted] |
| J3140 | Injection, testosterone suspension, up to 50 mg [deleted] |
| J3145 | Injection, testosterone undecanoate, 1 mg |
| J3150 | Injection, testosterone propionate, up to 100 mg [deleted] |
| J3355 | Injection, urofollitropin, 75 iu |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg |
| J8515 | Cabergoline, oral, 0.25 mg |
| J8540 | Dexamethasone, oral, 0.25 mg |
| J9202 | Goserelin acetate implant, per 3.6 mg |
| J9218 | Leuprolide acetate, per 1 mg |
| P3000 | Screening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision |
| P3001 | Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician |
| Q0115 | Post-coital direct, qualitative examinations of vaginal or cervical mucous |
| S0122 | Injection, menotropins, 75 iu |
| S0126 | Injection, follitropin alfa, 75 iu |
| S0128 | Injection, follitropin beta, 75 iu |
| S0132 | Injection, ganirelix acetate, 250 mcg |
| S0187 | Tamoxifen citrate, oral, 10 mg |
| S0265 | Genetic counseling, under physician supervision, each 15 minutes |
| S2078 | LAPAROSCOPIC SUPRACERVICAL HYSTERECTOMY (SUBTOTAL HYSTERECTOMY), WITH OR WITHOUT REMOVAL OF TUBE(S), WITH OR WITHOUT REMOVAL OF OVARY(S) [deleted] |
| S4011 | In vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development |
| S4013 | Complete cycle, gamete intrafallopian transfer (gift), case rate |
| S4014 | Complete cycle, zygote intrafallopian transfer (zift), case rate |
| S4015 | Complete in vitro fertilization cycle, not otherwise specified, case rate |
| S4016 | Frozen in vitro fertilization cycle, case rate |
| S4017 | Incomplete cycle, treatment cancelled prior to stimulation, case rate |
| S4018 | Frozen embryo transfer procedure cancelled before transfer, case rate |
| S4020 | In vitro fertilization procedure cancelled before aspiration, case rate |
| S4021 | In vitro fertilization procedure cancelled after aspiration, case rate |
| S4022 | Assisted oocyte fertilization, case rate |
| S4023 | Donor egg cycle, incomplete, case rate |
| S4025 | Donor services for in vitro fertilization (sperm or embryo), case rate |
| S4026 | Procurement of donor sperm from sperm bank |
| S4028 | Microsurgical epididymal sperm aspiration (mesa) |
| S4035 | Stimulated intrauterine insemination (iui), case rate |
| S4037 | Cryopreserved embryo transfer, case rate |
| S4993 | Contraceptive pills for birth control |
| S9560 | Home injectable therapy; hormonal therapy (e.g.; leuprolide, goserelin), including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
| No matching codes found | |
|
Code
|
Description
|
|---|---|
| 447.0 | Arteriovenous fistula, acquired |
| No matching codes found | |